These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 15942563

  • 1. Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung cancer for dose-dependent effect.
    Sievers EM, Bart RD, Backhus LM, Lin Y, Starnes M, Castanos R, Starnes VA, Bremner RM.
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1242-9. PubMed ID: 15942563
    [Abstract] [Full Text] [Related]

  • 2. Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer.
    Backhus LM, Sievers E, Lin GY, Castanos R, Bart RD, Starnes VA, Bremner RM.
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):297-303. PubMed ID: 16872953
    [Abstract] [Full Text] [Related]

  • 3. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L, Chen W, Xie X, He Y, Bai X.
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [Abstract] [Full Text] [Related]

  • 4. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
    Liu W, Chen Y, Wang W, Keng P, Finkelstein J, Hu D, Liang L, Guo M, Fenton B, Okunieff P, Ding I.
    Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
    Narayanan BA, Narayanan NK, Pttman B, Reddy BS.
    Prostate; 2006 Feb 15; 66(3):257-65. PubMed ID: 16175586
    [Abstract] [Full Text] [Related]

  • 7. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 8. Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.
    Zheng X, Cui XX, Avila GE, Huang MT, Liu Y, Patel J, Kong AN, Paulino R, Shih WJ, Lin Y, Rabson AB, Reddy BS, Conney AH.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5480-7. PubMed ID: 17875778
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells.
    Qin J, Yuan J, Li L, Liu H, Qin R, Qin W, Chen B, Wang H, Wu K.
    Biomed Pharmacother; 2009 Mar 15; 63(3):241-8. PubMed ID: 18617357
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS, Liu DS, Dai CW, Li RJ.
    Am J Hematol; 2006 Apr 15; 81(4):242-55. PubMed ID: 16550520
    [Abstract] [Full Text] [Related]

  • 12. The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice.
    Klenke FM, Gebhard MM, Ewerbeck V, Abdollahi A, Huber PE, Sckell A.
    BMC Cancer; 2006 Jan 12; 6():9. PubMed ID: 16409625
    [Abstract] [Full Text] [Related]

  • 13. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
    Reddy BS, Patlolla JM, Simi B, Wang SH, Rao CV.
    Cancer Res; 2005 Sep 01; 65(17):8022-7. PubMed ID: 16140976
    [Abstract] [Full Text] [Related]

  • 14. Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo.
    Grimes KR, Warren GW, Fang F, Xu Y, St Clair WH.
    Oncol Rep; 2006 Oct 01; 16(4):771-6. PubMed ID: 16969492
    [Abstract] [Full Text] [Related]

  • 15. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
    Narayanan BA, Reddy BS, Bosland MC, Nargi D, Horton L, Randolph C, Narayanan NK.
    Clin Cancer Res; 2007 Oct 01; 13(19):5965-73. PubMed ID: 17908994
    [Abstract] [Full Text] [Related]

  • 16. Effect of celecoxib and the novel anti-cancer agent, dimethylamino-parthenolide, in a developmental model of pancreatic cancer.
    Yip-Schneider MT, Wu H, Njoku V, Ralstin M, Holcomb B, Crooks PA, Neelakantan S, Sweeney CJ, Schmidt CM.
    Pancreas; 2008 Oct 01; 37(3):e45-53. PubMed ID: 18815538
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxicity of a non-cyclooxygenase-2 inhibitory derivative of celecoxib in non-small-cell lung cancer A549 cells.
    Tong Z, Wu X, Chen CS, Kehrer JP.
    Lung Cancer; 2006 Apr 01; 52(1):117-24. PubMed ID: 16497409
    [Abstract] [Full Text] [Related]

  • 18. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
    Zuo CH, Li ZR, Zhou X, Ouyang YZ, Zhou ZY, Zeng L.
    Ai Zheng; 2006 Apr 01; 25(4):414-20. PubMed ID: 16613672
    [Abstract] [Full Text] [Related]

  • 19. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094
    [Abstract] [Full Text] [Related]

  • 20. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.
    Mao JT, Roth MD, Serio KJ, Baratelli F, Zhu L, Holmes EC, Strieter RM, Dubinett SM.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5835-41. PubMed ID: 14676104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.